palmidrol has been researched along with evans blue in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Canella, R; Leon, A; Marcolongo, G; Mazzari, S; Petrelli, L | 1 |
1 other study(ies) available for palmidrol and evans blue
Article | Year |
---|---|
N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation.
Topics: Amides; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cell Degranulation; Dextrans; Ear, External; Edema; Endocannabinoids; Ethanolamines; Evans Blue; Excipients; Extravasation of Diagnostic and Therapeutic Materials; Female; Formaldehyde; Hyperalgesia; Male; Mast Cells; Mice; Mice, Inbred BALB C; Palmitic Acids; Passive Cutaneous Anaphylaxis; Rats; Rats, Wistar; Substance P | 1996 |